United Guardian (UG) Research & Development (2014 - 2026)
United Guardian's (UG) quarterly Research & Development came in at $124395.0 in Q2 2026, up 15.32% year-over-year from $107868.0 in Q2 2025, and up 8.15% quarter-over-quarter from $115021.0 in Q1 2026.
Analysis
United Guardian (UG) Research & Development (2014 - 2026) Analysis & Trends
United Guardian has disclosed Research & Development across 13 years of filings, most recently posting $124395.0 for Q2 2026.
- In Q2 2026, Research & Development rose 15.32% year-over-year to $124395.0; the TTM figure through Jun 2026 stood at $480798.0 (up 3.53% YoY), while the FY2025 annual figure was $463644.0, up 1.5% from the prior year.
- Research & Development came in at $124395.0 for Q2 2026 at United Guardian, up from $115021.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $131666.0 in Q1 2022 to a low of $98141.0 in Q3 2023.
- Average Research & Development over 5 years is $117477.8, with a median of $116062.5 recorded in 2025.
- Year-over-year, Research & Development jumped 49.14% in 2022 and retreated 18.89% in 2024.
- Over 5 years, Research & Development stood at $125914.0 in 2022, then fell by 12.51% to $110163.0 in 2023, then grew by 18.97% to $131065.0 in 2024, then retreated by 5.18% to $124278.0 in 2025, then gained by 0.09% to $124395.0 in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $124395.0 in Q2 2026, $115021.0 in Q1 2026, and $124278.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.10 Bn | 627.34 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 364.97 Bn | 357.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 267.08 Bn | 259.39 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Pfizer | 158.83 Bn | 147.13 Bn | 10.94 Bn | 2.81 Bn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn | -2.60 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - | 394.92 Mn |
| 8 | Incyte | 25.35 Bn | 20.81 Bn | 1.57 Bn | 516.95 Mn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 146.30 Mn |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 124,395.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124,395.00 |
| Mar 31, 2026 | 115,021.00 |
| Dec 31, 2025 | 124,278.00 |
| Sep 30, 2025 | 117,104.00 |
| Jun 30, 2025 | 107,868.00 |
| Mar 31, 2025 | 114,394.00 |
| Dec 31, 2024 | 131,065.00 |
| Sep 30, 2024 | 111,072.00 |
| Jun 30, 2024 | 111,660.00 |
| Mar 31, 2024 | 102,982.00 |
| Dec 31, 2023 | 110,163.00 |
| Sep 30, 2023 | 98,141.00 |
| Jun 30, 2023 | 128,729.00 |
| Mar 31, 2023 | 126,959.00 |
| Dec 31, 2022 | 125,914.00 |
| Sep 30, 2022 | 120,924.00 |
| Jun 30, 2022 | 112,266.00 |
| Mar 31, 2022 | 131,666.00 |
| Dec 31, 2021 | 129,589.00 |
| Sep 30, 2021 | 130,742.00 |